Kelly Zhang is a Senior Fellow and Director at Genentech. She leads analytical R&D teams on both drug substance and drug formulation. She has over 20 years of pharmaceutical industry experience at Genentech, Allergan and Pfizer. She has published over 80 peer-reviewed papers in the field of pharmaceutical analysis, covering synthetic molecules, biologic conjugates and nucleic acid based medicines. She is a member of the Permanent Scientific Committee of the International HPLC Conferences and the International Pharmaceutical and Biomedical Analysis Conference.
Kelly was interviewed at ISC 2024 by LCGC international and answered the following questions related to analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
PFAS Analysis in Practice: A RAFA 2024 Interview with Stefan van Leuwen
January 10th 2025At the Recent Advances in Food Analysis (RAFA) conference in 2024, LCGC International sat down with Stefan van Leuwen of Wageningen Food Safety Research to discuss his research, which addresses emerging challenges in circular food production, focusing on the risks posed by pollutants when waste and by-products are repurposed in food systems.
Using Chromatography to Study Microplastics in Food: An Interview with Jose Bernal
December 16th 2024LCGC International sat down with Jose Bernal to discuss his latest research in using pyrolysis gas chromatography–mass spectrometry (Py-GC–MS) and other chromatographic techniques in studying microplastics in food analysis.
The Use of SPME and GC×GC in Food Analysis: An Interview with Giorgia Purcaro
December 16th 2024LCGC International sat down with Giorgia Purcaro of the University of Liege to discuss the impact that solid-phase microextraction (SPME) and comprehensive multidimensional gas chromatography (GC×GC) is having on food analysis.